Skip to content

How a London clinic reduced new HIV infections by 90% and why more European cities can do the same

'A new service design for asymptomatic screening' slide from Dean Street presentation at EACS 2017.

ABX464 reduces HIV reservoir but doesn’t delay viral rebound

Linos Vandekerckhove presenting at EACS 2017. Photo by BHIVA.

Boosted protease inhibitor and lamivudine provides effective maintenance treatment

Boosted protease inhibitor and lamivudine provides effective maintenance treatment

Daily aspirin therapy linked to lower liver cancer risk

Image: carballo/Shutterstock.com

Hepatitis C testing linked to reduced opioid use among people who inject drugs

Hooman Farhang Zangneh presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com

Maviret cures most people with HCV genotype 3 and those with cirrhosis

Steven Flamm presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com

HCV infection is rising among HIV-positive gay men in San Diego

Antoine Chaillon presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com

Hepatitis C cure leads to improved quality of life

Zobair Younossi presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com

A year of generic PrEP could recoup its own cost within five years if effectiveness is high, Public Health England model finds